Nrxp; nrxpw shareholder alert: bronstein, gewirtz & grossman, llc notifies nrx pharmaceuticals, inc. investors of class action and lead plaintiff deadline: march 21, 2022

New york--(business wire)--bronstein, gewirtz & grossman, llc notifies investors that a class action lawsuit has been filed against nrx pharmaceuticals, inc. (“nrx” or the “company”) (nasdaq: nrxp; nrxpw) on behalf of purchasers of nrx securities between june 1, 2021 and november 4, 2021, both dates inclusive (the “class period”). such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/nrxp. this class action seeks to recover damages against defendants fo
NRXP Ratings Summary
NRXP Quant Ranking